CStone Pharmaceuticals Statistics
Total Valuation
CSPHF has a market cap or net worth of 1.29 billion. The enterprise value is 1.25 billion.
| Market Cap | 1.29B |
| Enterprise Value | 1.25B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 1.46B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.61% |
| Shares Change (QoQ) | +2.92% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.09B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 45.63 |
| PB Ratio | 29.33 |
| P/TBV Ratio | 57.92 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -23.70 |
| EV / Sales | 43.76 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 1.24.
| Current Ratio | 1.44 |
| Quick Ratio | 1.20 |
| Debt / Equity | 1.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -26.87 |
Financial Efficiency
Return on equity (ROE) is -96.36% and return on invested capital (ROIC) is -30.56%.
| Return on Equity (ROE) | -96.36% |
| Return on Assets (ROA) | -16.93% |
| Return on Invested Capital (ROIC) | -30.56% |
| Return on Capital Employed (ROCE) | -65.16% |
| Revenue Per Employee | 215,770 |
| Profits Per Employee | -401,818 |
| Employee Count | 135 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 1.38 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +420.56% in the last 52 weeks. The beta is 0.20, so CSPHF's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | +420.56% |
| 50-Day Moving Average | 0.64 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 66.65 |
| Average Volume (20 Days) | 52,091 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSPHF had revenue of 28.27 million and -52.64 million in losses. Loss per share was -0.04.
| Revenue | 28.27M |
| Gross Profit | -3.44M |
| Operating Income | -51.49M |
| Pretax Income | -52.64M |
| Net Income | -52.64M |
| EBITDA | -49.74M |
| EBIT | -51.49M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 96.33 million in cash and 54.63 million in debt, giving a net cash position of 41.70 million.
| Cash & Cash Equivalents | 96.33M |
| Total Debt | 54.63M |
| Net Cash | 41.70M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 43.98M |
| Book Value Per Share | 0.03 |
| Working Capital | 38.48M |
Cash Flow
| Operating Cash Flow | -60.07M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is -12.18%, with operating and profit margins of -182.16% and -186.23%.
| Gross Margin | -12.18% |
| Operating Margin | -182.16% |
| Pretax Margin | -186.23% |
| Profit Margin | -186.23% |
| EBITDA Margin | -175.96% |
| EBIT Margin | -182.16% |
| FCF Margin | n/a |
Dividends & Yields
CSPHF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.61% |
| Shareholder Yield | n/a |
| Earnings Yield | -4.08% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CSPHF has an Altman Z-Score of -9.6 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.6 |
| Piotroski F-Score | 1 |